Is Amylyx Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: AMLX) stock is to Strong Buy AMLX stock.
Out of 3 analysts, 2 (66.67%) are recommending AMLX as a Strong Buy, 1 (33.33%) are recommending AMLX as a Buy, 0 (0%) are recommending AMLX as a Hold, 0 (0%) are recommending AMLX as a Sell, and 0 (0%) are recommending AMLX as a Strong Sell.
What is AMLX's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: AMLX) forecast ROE is N/A, which is considered weak.
What is AMLX's Price Target?
According to 3 Wall Street analysts that have issued a 1 year AMLX price target, the average AMLX price target is $49.67, with the highest AMLX stock price forecast at $50.00 and the lowest AMLX stock price forecast at $49.00.
On average, Wall Street analysts predict that Amylyx Pharmaceuticals's share price could reach $49.67 by Aug 11, 2024. The average Amylyx Pharmaceuticals stock price prediction forecasts a potential upside of 168.76% from the current AMLX share price of $18.48.
What is AMLX's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: AMLX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.07%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.